Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma

Benzer Materyaller

• Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
  Yazar:: Narendranath Epperla, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-05-01)
• Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study
  Yazar:: Natalie S. Grover, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-10-01)
• Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma
  Yazar:: Adam J Olszewski, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-11-01)
• IBRUTİNİB-OBİNUTUZUMAB COMBİNATİON THERAPY İN THE TREATMENT OF RELAPSED NODAL MARGİNAL ZONE LYMPHOMA: A CASE STUDY
  Yazar:: Nuray Gül Açar, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-10-01)
• Acquired bone marrow aplasia and long-lasting complete remission with Loncastuximab Tesirine in a patient with transformed marginal zone lymphoma: a case report
  Yazar:: Lorenzo Esposito, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-05-01)